{
  "id": "af3e070ecd47a23a",
  "title": "STAT+: Solicitor general urges Supreme Court to review \u2018skinny labeling\u2019 and generic drug access",
  "description": "In a closely watched case, the U.S. solicitor general has urged the Supreme Court to review a controversy over so-called skinny labels for medicines, arguing that an appeals court finding&#8230;",
  "content": "In a closely watched case, the U.S. solicitor general has urged the Supreme Court to review a controversy over so-called skinny labels for medicines, arguing that an appeals court finding&#8230;",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2025/12/09/patents-pharma-generics-scotus-skinny-labels-medicines/?utm_campaign=rss",
  "published_at": "2025-12-09T21:43:10+00:00",
  "fetched_at": "2025-12-10T00:22:54.894572+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug",
    "supreme court"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Solicitor general urges Supreme Court to review \u2018skinny labeling\u2019 and generic drug access",
    "description": "In a closely watched case, the U.S. solicitor general has urged the Supreme Court to review a controversy over so-called skinny labels for medicines, arguing that an appeals court finding&#8230;",
    "url": "https://www.statnews.com/pharmalot/2025/12/09/patents-pharma-generics-scotus-skinny-labels-medicines/?utm_campaign=rss",
    "published": "2025-12-09T21:43:10+00:00",
    "source": "STAT"
  }
}